6505--Amiodarone HCL Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0014

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents3
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued a solicitation for the supply of Amiodarone HCL Tablets. This procurement, identified by number 36E79726R0014, seeks to secure a reliable source of this critical pharmaceutical product to support the ongoing healthcare needs of veterans served by the VA healthcare system. The scope of this solicitation encompasses the manufacturing and delivery of Amiodarone HCL Tablets, a medication commonly used in the management of certain cardiac arrhythmias. The intended outcome is to ensure a consistent and high-quality supply of this essential drug, thereby supporting the VA’s mission to provide comprehensive medical care to veterans nationwide. Key requirements for this procurement include compliance with the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing. Offerors must demonstrate the capability to manufacture and supply pharmaceutical products in accordance with all applicable federal regulations and quality standards. The Product Service Code (PSC) associated with this requirement is 6505, further specifying the focus on pharmaceutical and medicinal products. The contracting activity is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs. The primary point of contact for this solicitation is Deborah S. Fassl, who can be reached via email at [email protected] for any inquiries related to the opportunity. While the notice does not specify set-aside requirements or special considerations, interested contractors should review the solicitation documents and attachments available through the provided SAM.gov link for detailed instructions, evaluation criteria, and submission requirements. The procurement is classified as a solicitation, indicating that the VA is actively seeking competitive proposals from qualified manufacturers and suppliers. This opportunity is particularly relevant for contractors with established capabilities in pharmaceutical preparation manufacturing, robust quality assurance processes, and experience in federal healthcare supply contracts. The contract’s core requirements and objectives—ensuring the timely and compliant delivery of Amiodarone HCL Tablets—will remain constant throughout the contract lifecycle, supporting the VA’s commitment to veteran health and safety. For further information and to access the solicitation documents, contractors are encouraged to visit the official notice at https://sam.gov/opp/ac34c0868726475aae934c40c24aa127/view.